BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 38442713)

  • 1. Beta-defensin index: A functional biomarker for oral cancer detection.
    Ghosh SK; Man Y; Fraiwan A; Waters C; McKenzie C; Lu C; Pfau D; Kawsar H; Bhaskaran N; Pandiyan P; Jin G; Briggs F; Zender CC; Rezaee R; Panagakos F; Thuener JE; Wasman J; Tang A; Qari H; Wise-Draper T; McCormick TS; Madabhushi A; Gurkan UA; Weinberg A
    Cell Rep Med; 2024 Mar; 5(3):101447. PubMed ID: 38442713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human beta-defensin-1 suppresses tumor migration and invasion and is an independent predictor for survival of oral squamous cell carcinoma patients.
    Han Q; Wang R; Sun C; Jin X; Liu D; Zhao X; Wang L; Ji N; Li J; Zhou Y; Ye L; Liang X; Jiang L; Liao G; Dan H; Zeng X; Chen Q
    PLoS One; 2014; 9(3):e91867. PubMed ID: 24658581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human beta-defensin-1, -2, and -3 exhibit opposite effects on oral squamous cell carcinoma cell proliferation.
    Winter J; Pantelis A; Reich R; Martini M; Kraus D; Jepsen S; Allam JP; Novak N; Wenghoefer M
    Cancer Invest; 2011 Mar; 29(3):196-201. PubMed ID: 21280982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of human beta-defensin 1, 2, and 3 expression in oral squamous cell carcinoma.
    Joly S; Compton LM; Pujol C; Kurago ZB; Guthmiller JM
    Oral Microbiol Immunol; 2009 Oct; 24(5):353-60. PubMed ID: 19702947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human beta-defensin-3 (hBD-3) upregulated by LPS via epidermal growth factor receptor (EGFR) signaling pathways to enhance lymphatic invasion of oral squamous cell carcinoma.
    Shuyi Y; Feng W; Jing T; Hongzhang H; Haiyan W; Pingping M; Liwu Z; Zwahlen RA; Hongyu Y
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Nov; 112(5):616-25. PubMed ID: 22035653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased gene expression of human beta-defensin-1 in the development of squamous cell carcinoma of the oral cavity.
    Wenghoefer M; Pantelis A; Dommisch H; Reich R; Martini M; Allam JP; Novak N; Bergé S; Jepsen S; Winter J
    Int J Oral Maxillofac Surg; 2008 Jul; 37(7):660-3. PubMed ID: 18346877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point-of-care Analysis for Non-invasive Diagnosis of Oral cancer (PANDORA): A technology-development proof of concept diagnostic accuracy study of dielectrophoresis in patients with oral squamous cell carcinoma and dysplasia.
    Hughes MP; Labeed FH; Hoettges KF; Porter S; Mercadante V; Kalavrezos N; Liew C; McCaul JA; Kulkarni R; Cymerman J; Kerawala C; Barber J; Lewis MP; Fedele S
    J Oral Pathol Med; 2023 Apr; 52(4):305-314. PubMed ID: 36811206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of human beta-defensin-2 in intratumoral vascular endothelium and in endothelial cells induced by transforming growth factor beta.
    Kawsar HI; Ghosh SK; Hirsch SA; Koon HB; Weinberg A; Jin G
    Peptides; 2010 Feb; 31(2):195-201. PubMed ID: 20006664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profile of human beta-defensin 3 in oral squamous cell carcinoma.
    Kesting MR; Loeffelbein DJ; Hasler RJ; Wolff KD; Rittig A; Schulte M; Hirsch T; Wagenpfeil S; Jacobsen F; Steinstraesser L
    Cancer Invest; 2009 Jun; 27(5):575-81. PubMed ID: 19219676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High concentration of beta-defensin-2 in oral squamous cell carcinoma.
    Sawaki K; Mizukawa N; Yamaai T; Yoshimoto T; Nakano M; Sugahara T
    Anticancer Res; 2002; 22(4):2103-7. PubMed ID: 12174890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of human beta-defensin 2 in keratinized and non-keratinized oral epithelial lesions; immunohistochemistry and in situ hybridization.
    Abiko Y; Suraweera AK; Nishimura M; Arakawa T; Takuma T; Mizoguchi I; Kaku T
    Virchows Arch; 2001 Mar; 438(3):248-53. PubMed ID: 11315621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral carcinogenesis and non-invasive biomarkers for the diagnosis of oral squamous cell carcinoma.
    Khan S; Alamgir MM
    J Pak Med Assoc; 2024 Feb; 74(2):370-373. PubMed ID: 38419239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmable bio-nanochip-based cytologic testing of oral potentially malignant disorders in Fanconi anemia.
    Floriano PN; Abram T; Taylor L; Le C; Talavera H; Nguyen M; Raja R; Gillenwater A; McDevitt J; Vigneswaran N
    Oral Dis; 2015 Jul; 21(5):593-601. PubMed ID: 25662766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Oral Microbial Biomarker for Early Detection of Recurrence of Oral Squamous Cell Carcinoma.
    Lyu WN; Lin MC; Shen CY; Chen LH; Lee YH; Chen SK; Lai LC; Chuang EY; Lou PJ; Tsai MH
    ACS Infect Dis; 2023 Sep; 9(9):1783-1792. PubMed ID: 37565768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different expression patterns of beta-defensins in human squamous cell carcinomas.
    Yoshimoto T; Yamaai T; Mizukawa N; Sawaki K; Nakano M; Yamachika E; Sugahara T
    Anticancer Res; 2003; 23(6C):4629-33. PubMed ID: 14981906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOD1, RIP2 and Caspase12 are potentially novel biomarkers for oral squamous cell carcinoma development and progression.
    Wang X; Jiang W; Duan N; Qian Y; Zhou Q; Ye P; Jiang H; Bai Y; Zhang W; Wang W
    Int J Clin Exp Pathol; 2014; 7(4):1677-86. PubMed ID: 24817964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of expression of beta-defensins in oral squamous cell carcinoma.
    Abiko Y; Mitamura J; Nishimura M; Muramatsu T; Inoue T; Shimono M; Kaku T
    Cancer Lett; 1999 Aug; 143(1):37-43. PubMed ID: 10465335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Squamous Cell Carcinoma Associated with Precursor Lesions.
    McCord C; Kiss A; Magalhaes MA; Leong IT; Jorden T; Bradley G
    Cancer Prev Res (Phila); 2021 Sep; 14(9):873-884. PubMed ID: 34193432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surrounding cells affect the gene expression pattern of human beta-defensins in squamous cell carcinoma in vitro.
    Kida-Takaoka S; Yamaai T; Mizukawa N; Murakami J; Iida S
    Anticancer Res; 2014 Nov; 34(11):6443-9. PubMed ID: 25368244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour mismatch repair protein loss is associated with advanced stage in oral cavity squamous cell carcinoma.
    Vasan K; Satgunaseelan L; Anand S; Asher R; Selinger C; Low TH; Palme CE; Clark JR; Gupta R
    Pathology; 2019 Dec; 51(7):688-695. PubMed ID: 31630878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.